November 2, 2017 - Fischer Medical announced the submission of its 510(k) application with the U.S. Food and Drug Administration (FDA) for clearance of the Bloom 2 Cardiac Stimulator About the author superadmin Related postsMarch 13, 2026 – Fischer attending Access ASC Summit in Scottsdale, AZFebruary 17, 2026April 24, 2026 – Fischer attending HRS in Chicago, IL – Booth #1808 & 1908February 17, 2026April 24, 2025 – Fischer attending HRS in San Diego, CA – Booth #2605February 21, 2025February 5, 2024 – Health Canada approves Bloom 2 for use in Canada under License 110769February 21, 2025November 27, 2024 – Fischer inks Channel Partnership Agreement with GE Health for Centricity Cardio EnterpriseFebruary 21, 2025May 17-19, 2024 – FISCHER & SCHWARZER CARDIOTEK ATTEND HRS 2024 BOOTH#941/943January 24, 2024
February 5, 2024 – Health Canada approves Bloom 2 for use in Canada under License 110769February 21, 2025
November 27, 2024 – Fischer inks Channel Partnership Agreement with GE Health for Centricity Cardio EnterpriseFebruary 21, 2025
